IR-News

AUSSENDER



Marinomed Biotech AG
Ansprechpartner: Pascal Schmidt, CFO
Tel.: +43 2262 90300
E-Mail: pascal.schmidt@marinomed.com

FRüHERE MELDUNGEN

pta20220518027
Change of total number of voting rights and capital according to article 135 section 1 BörseG

Marinomed Biotech AG: Correction - Change of total number of voting rights and capital according to article 135 section 1 BörseG


Korneuburg (pta027/18.05.2022/14:20) - Correction: The change of the total number of voting rights is effective end of April 2022, not May 2022, as stated in the previous announcement. The corrected version shall read as follows:

Marinomed Biotech AG hereby announces that due to the exercise of the convertible bond with Nice & Green the total number of voting rights at the end of April 2022 has increased to 1,496,287 and the new stated capital amounts to EUR 1,496,287. The change of total voting rights has been effective since April 26, 2022.

(end)
emitter: Marinomed Biotech AG
Hovengasse 25
2100 Korneuburg
Austria
contact person: Pascal Schmidt, CFO
phone: +43 2262 90300
e-mail: pascal.schmidt@marinomed.com
website: www.marinomed.com
stock exchanges: official trade in Vienna
ISIN(s): ATMARINOMED6 (share)
|
|
98.729 Abonnenten
|
202.014 Meldungen
|
83.571 Pressefotos
Top